A Randomized, Open-label, Parallel Group, Multicenter Phase IV Study to Assess Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management:TICAKOREA Trial
Phase of Trial: Phase IV
Latest Information Update: 25 Sep 2019
Price : $35 *
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Acute coronary syndromes
- Focus Adverse reactions; Therapeutic Use
- Acronyms TICA KOREA
- 25 Sep 2019 Results published in the Circulation.
- 28 Nov 2018 Status changed from active, no longer recruiting to completed.
- 19 Jun 2017 Status changed from recruiting to active, no longer recruiting.